Combination therapy using a substituted pyrimidin-4(3h)-one and nivolumab as well as its use in the treatment of cancer
US-2025268900-A1 · Aug 28, 2025 · US
Sun Yuting is listed as an inventor on 6 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Sun Yuting |
| Total patents | 6 |
| First publication | Sep 24, 2020 |
| Latest publication | Aug 28, 2025 |
Publications ranked by popularity score, then publication date.
US-2025268900-A1 · Aug 28, 2025 · US
US-11720757-B2 · Aug 8, 2023 · US
US-2023043993-A1 · Feb 9, 2023 · US
US-11003863-B2 · May 11, 2021 · US
US-2021056169-A1 · Feb 25, 2021 · US
US-2020302019-A1 · Sep 24, 2020 · US
Latest publications not already listed above.
No data yet.
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Microsoft Technology Licensing Llc | 4 |
| Oracle Int Corp | 1 |
| Bristol Myers Squibb Co | 1 |
| Navire Pharma Inc | 1 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| G06N20/00 | 5 |
| G06F40/295 | 4 |
| G06F40/30 | 4 |
| G06N3/0499 | 2 |
| G06F40/35 | 2 |